共 4 条
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients
被引:549
作者:
Kirklin, James K.
[1
]
Naftel, David C.
[1
]
Kormos, Robert L.
[2
]
Stevenson, Lynne W.
[3
]
Pagani, Francis D.
[4
]
Miller, Marissa A.
[5
]
Baldwin, J. Timothy
[5
]
Young, James B.
[6
]
机构:
[1] Univ Alabama Birmingham, Birmingham, AL 35294 USA
[2] Univ Pittsburgh, Presbyterian Univ Hosp, Med Ctr, Pittsburgh, PA USA
[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] NHLBI, Bethesda, MD 20892 USA
[6] Cleveland Clin Fdn, Lerner Coll Med, Cleveland, OH 44195 USA
关键词:
mechanical support;
ventricular assist devices;
INTERMACS;
advanced heart failure;
destination therapy;
D O I:
10.1016/j.healun.2012.12.004
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection. The current analysis includes more than 6000 patients and updated risk factors for continuous flow pumps. Among continuous flow pumps, actuarial survival is 80% at 1 year and 70% at 2 years. Quality of life indicators are generally favorable and adverse event burden will likely influence patient selections of advanced heart failure therapies. J Heart Lung Transplant 2013;32:141-156 (c) 2013 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:141 / 156
页数:16
相关论文